926010-67-5

Upstream product

• 926010-66-4 C₂₉H₅₄O₄Si₂ 
• 926010-57-3 C₂₁H₄₆O₃Si₂ 
• 926010-65-3 C₂₂H₄₆O₄Si₂ 
• 926010-64-2 C₁₀H₁₈O₄ 
• 926010-56-2 C₁₈H₂₆O₅ 

Downstream Products

• 926010-58-4 5,13,19-tris-(tert-butyl-dimethyl-silanyloxy)-7-hydroxy-1,21-bis-(4-methoxy-benzyloxy)-4,6,12,14,16,18,20,22-octamethyl-hexacosa-2,10,15,23,25-pentaen-9-one 
• 926010-59-5 5,13,19-tris-(tert-butyl-dimethyl-silanyloxy)-1,21-bis-(4-methoxy-benzyloxy)-4,6,12,14,16,18,20,22-octamethyl-hexacosa-2,10,15,23,25-pentaene-7,9-diol 
• 926010-62-0 4-[4,10-bis-(tert-butyl-dimethyl-silanyloxy)-12-(4-methoxy-benzyloxy)-3,5,7,9,11,13-hexamethyl-heptadeca-1,6,14,16-tetraenyl]-6-[2-(tert-butyl-dimethyl-silanyloxy)-6-(4-methoxy-benzyloxy)-1,3-dimethyl-hex-4-enyl]-2,2-dimethyl-[1,3]dioxane 
• 926010-55-1 C₂₃H₃₈O₄Si 

Relevant academic research and scientific papers

Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol

The design, synthesis, and biological evaluation of a series of hybrids and analogues of the microtubule-stabilizing anticancer agents dictyostatin, discodermolide, and taxol is described. A 22-membered macrolide scaffold was prepared by adapting earlier